Prosecution Insights
Last updated: November 16, 2026
Application No. 18/413,749

CONTACTLESS SENSOR-DRIVEN DEVICE, SYSTEM AND METHOD ENABLING CARDIOVASCULAR AND RESPIRATORY ASSESSMENT BASED ON FACE AND HAND IMAGING

Final Rejection §101
Filed
Jan 16, 2024
Priority
Jan 20, 2023 — provisional 63/440,241
Examiner
LEVICKY, WILLIAM J
Art Unit
3792
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Norbert Health, Inc.
OA Round
2 (Final)
70%
Grant Probability
Favorable
3-4
OA Rounds
99%
With Interview

Examiner Intelligence

Grants 70% — above average
70%
Career Allowance Rate
417 granted / 599 resolved
At TC average
Strong +29% interview lift
Without
With
+29.3%
Interview Lift
resolved cases with interview
Typical timeline
Avg Prosecution
46 currently pending
Career history
668
Total Applications
across all art units

Office Action

§101
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Response to Arguments The amendment to claims 10 and 19 are sufficient to overcome the previous objections. Applicant's arguments filed 8/3/2026 have been fully considered but they are not persuasive. The Applicant argues that acquiring data by segmenting skin areas into regions of interest cannot be performed in the human mind. The Applicant argues the image based segmentation of skin areas across multiple image frames constitutes the type of computer data structure manipulation that the human mind is not equipped to perform. The examiner respectfully disagrees as the human mind can segment skin areas into regions of interest in a plurality of images in which both the face and the palmar side of the hand are captured to acquire pleth signals. Regarding the 103 rejection, the argument regarding the newly added limitations is persuasive and the previous 103 rejection has been withdrawn. Claim Rejections - 35 USC § 101 35 U.S.C. 101 reads as follows: Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefor, subject to the conditions and requirements of this title. Claims 1-20 are rejected under 35 U.S.C. 101 because the claimed invention is directed to abstract idea without significantly more. The claim(s) recite(s) a mental task of acquire a first pleth signal based at least in part on capturing ambient light reflected from at least one region of interest (ROI) on a face of the subject; acquire a second pleth signal from a palmar side of a hand of the subject, wherein the first pleth signal and the second pleth signal are each acquired by segmenting skin areas into regions of interest in a plurality of image frames in which both the face and the palmar side of the hand of the subject are captured; compute a confidence score for the first pleth signal or the second pleth signal; and compute estimates of at least one vital sign of the subject from the first and second pleth signals and combining the estimates into a final estimate of at least one vital sign based on the confidence score. This judicial exception is not integrated into a practical application because the additional elements of a camera are a pre-solution activity used for obtaining data used and the processing device is a generic computing structure used to perform the abstract idea (e.g. Paragraphs [0037] and [0061] of the published disclosure). The claim(s) does/do not include additional elements that are sufficient to amount to significantly more than the judicial exception because cameras are well-known routine and conventional. The examiner takes official notice that cameras are part of computers including mobile communication devices and that the processing device is a generic processing device as indicated by the instant disclosure and therefore does not amount to significantly more than the abstract idea itself. The dependent claims do not recite any additional elements and instead discuss the aspects of the abstract idea. Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. McCann et al (US Publication 2020/0163586) discloses confidence of PPG measurement based on movement. Lafon et al (US Publication 2020/0000441) discloses the PPG device assigns different weights based on confidence metrics associated with the PPG signals. Jones et al (US Publication 2022/0008019) discloses removing PPG with low confidence (likely motion) and weight based PPG in heart rate prediction. Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to William J Levicky whose telephone number is (571)270-3983. The examiner can normally be reached Monday-Thursday 8AM-5PM EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, David Hamaoui can be reached at (571)270-5625. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /William J Levicky/Primary Examiner, Art Unit 3796
Read full office action

Prosecution Timeline

Jan 16, 2024
Application Filed
Feb 03, 2026
Non-Final Rejection mailed — §101
Aug 03, 2026
Response Filed
Sep 24, 2026
Final Rejection mailed — §101 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12788505
RELAXATION TENSION MONITORING AND HOMING OF MEDICAL INSTRUMENTS
2y 9m to grant Granted Nov 10, 2026
Patent 12773562
MEDICAL DEVICE AND METHOD FOR DETERMINING ATRIOVENTRICULAR SYNCHRONY
2y 11m to grant Granted Oct 27, 2026
Patent 12766325
METHODS FOR TREATING THE SYMPTOMS OF NOCTURIA
5y 2m to grant Granted Oct 20, 2026
Patent 12752101
ELECTRICAL STIMULATION OF TISSUE
4y 7m to grant Granted Oct 06, 2026
Patent 12746397
BIORESORBABLE CARDIOVASCULAR INSTRUMENTS, AND OPERATION AND FABRICATION METHODS OF SAME
2y 9m to grant Granted Sep 29, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
70%
Grant Probability
99%
With Interview (+29.3%)
Moderate
PTA Risk
Based on 599 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month